Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 26S proteasome is a large, ATP-dependent multi-protein complex responsible for the regulated degradation of ubiquitinated proteins in eukaryotic cells. The β1-subunit, also known as PSMB1, possesses caspase-like peptidyl-glutamyl peptide-hydrolyzing activity within the 20S core particle. It is a key component of protein quality control and regulation of various cellular processes. Inhibition of the proteasome, including the β1 subunit, is a therapeutic strategy in diseases like multiple myeloma.
Inhibition of proteasome activity; specifically caspase-like activity of the beta-1 subunit.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S Proteasome (β1-Subunit) (None).